Displaying drugs 5351 - 5375 of 11303 in total
Amuvatinib
Amuvatinib has been used in trials studying the treatment of Solid Tumors and Small Cell Lung Carcinoma. Amuvatinib is an oral, selective multi-targeted tyrosine kinase inhibitor that suppresses c-MET, c-RET and the mutant forms of c-KIT, PDGFR and FLT3. Amuvatinib also suppresses Rad51 protein, a critical component of double-stranded DNA...
Investigational
Matched Description: … Amuvatinib also suppresses Rad51 protein, a critical component of double-stranded DNA repair in cancer …
Pipemidic acid
Experimental
Amotosalen
Investigational
ICG-001
Investigational
Remacemide
Investigational
Matched Categories: … Compounds used in a research, industrial, or household setting …
Epigallocatechin gallate
Epigallocatechin gallate has been investigated for the treatment of Hypertension and Diabetic Nephropathy.
Investigational
Matched Categories: … Compounds used in a research, industrial, or household setting …
Homidium
Homidium is a group II compound with trypanocidal effects.
Investigational
Matched Description: … Homidium is a group II compound with trypanocidal effects.[A253017] …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Matched Categories: … Compounds used in a research, industrial, or household setting …
Acetoacetic acid
Experimental
Alpha-L-Arabinose
Experimental
Arachidonic Acid
An unsaturated, essential fatty acid. It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent of animal phosphatides. It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins, thromboxanes,...
Experimental
Matched Description: … It is found in animal and human fat as well as in the liver, brain, and glandular organs, and is a constituent ... It is formed by the synthesis from dietary linoleic acid and is a precursor in the biosynthesis of prostaglandins …
ADH-1
Adherex's biotechnology compound, ADH-1, targets N-cadherin, a protein present on certain tumor cells and established tumor blood vessels. ADH-1 is currently in clinical development in a combination program with a range of chemotherapeutic agents to investigate the synergistic effects noted in our preclinical models. At the end of 2006, the...
Investigational
Matched Description: … ADH-1 is currently in clinical development in a combination program with a range of chemotherapeutic ... ADH-1 may have utility in a wide variety of cancers as N-cadherin is overexpressed in a variety of tumors ... Adherex's biotechnology compound, ADH-1, targets N-cadherin, a protein present on certain tumor cells …
AKV-9
Investigational
(S)-AMPA
AMPA is a specific agonist for the AMPA receptor.
Experimental
Matched Description: … AMPA is a specific agonist for the AMPA receptor. …
AC-100
AC-100 is a novel synthetic peptide derived from an endogenous human protein produced by bone and dental cells (a fragment from matrix extracellular phosphoglycoprotein). It is being developed by Acologix, Inc.
Investigational
Matched Description: … cells (a fragment from matrix extracellular phosphoglycoprotein). ... AC-100 is a novel synthetic peptide derived from an endogenous human protein produced by bone and dental …
AEM-28
AEM-28 is a 28 amino acid mimetic of apolipoprotein E being investigated for lipid disorders, such as homozygous familial hypercholesterolemia. It possesses anti-inflammatory properties.
Investigational
Matched Description: … AEM-28 is a 28 amino acid mimetic of apolipoprotein E being investigated for lipid disorders, such as …
AP-101
AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1.
Investigational
Matched Description: … AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1. …
ATX-01
ATX-01 is an antimiR, a chemically modified antisense oligonucleotide, designed to target microRNA 23b (miR-23b).
Investigational
Matched Description: … ATX-01 is an antimiR, a chemically modified antisense oligonucleotide, designed to target microRNA 23b …
AGuIX
AGuIX is an investigational brand product consisting of a polysiloxane matrix and gadolinium chelates. It is under development as a radiosensitizer to be used during radiation treatment of malignant glioma.
Investigational
Matched Description: … AGuIX is an investigational brand product consisting of a polysiloxane matrix and gadolinium chelates ... It is under development as a radiosensitizer to be used during radiation treatment of malignant glioma …
AD-114
Investigational
AVR-48
Investigational
Larsucosterol
Investigational
Matched Iupac: … -methylheptan-2-yl]-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a] …
Azelnidipine
Azelnidipine is a dihydropyridine calcium channel blocker. It is marketed by Daiichi-Sankyo pharmaceuticals, Inc. in Japan. It has a gradual onset of action and produces a long-lasting decrease in blood pressure, with only a small increase in heart rate, unlike some other calcium channel blockers . It is currently being...
Investigational
Matched Description: … It has a gradual onset of action and produces a long-lasting decrease in blood pressure, with only a ... Azelnidipine is a dihydropyridine calcium channel blocker. …
BACTEK-R
MV130 contains different components of whole heat-inactivated gram-positive and -negative bacteria that are involved in upper and lower respiratory infections. These include streptococcus pneumoniae and staphylococcus aureus. Though studies have shown that it reduces the rate of infections in recurrent respiratory tract infections (RRTIs), the complete mechanisms are not fully...
Investigational
Matched Description: … MV130 contains different components of whole heat-inactivated gram-positive and -negative bacteria that …
Cholesteryl Linoleate
Experimental
Matched Iupac: … 11a-dimethyl-1-[(2R)-6-methylheptan-2-yl]-1H,2H,3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a] …
Displaying drugs 5351 - 5375 of 11303 in total